Table 2.
Study | Bact. cure | New IMI | Clinical cure | SCC | Recurrence | Milk yield | Culling |
---|---|---|---|---|---|---|---|
NEGATIVELY CONTROLLED RANDOMIZED CLINICAL TRIALS | |||||||
Roberson et al. (39) | NSDa | NSD | NSD | SIGb | Defined as CC NSD | SIG | |
Suojala et al. (27) | NSD | NSD at day 21 | No stats | NSD | |||
Schukken et al. (40) | SIG | SIG | NSD | NSD | SIG | ||
Persson et al. (41) | SIG | ||||||
Fuenzalida and Ruegg (22) | NSD | NSD | NSD | NSD | NSD | NSD | |
Fuenzalida and Ruegg (25) | SIG | NSD | NSD | NSD | NSD | NSD | |
POSITIVELY CONTROLLED TRIALS – NOT TESTING A NON-INFERIORITY HYPOTHESIS | |||||||
Erskine et al. (34) | NSD | ||||||
Wraight (42) | NSD | NSD | |||||
McDougall (43) | NSD | SIG | NSD | SIG | NSD | ||
Taponen et al. (44) | NSD | NSD | |||||
Sérieys et al. (45) | NSD | NSD | SIG | ||||
Taponen et al. (46) | SIG | NSD | |||||
Wenz et al. (33) | NSD | NSD | NSD | ||||
Bradley and Green (47) | NSD | NSD | |||||
Swinkels et al. (48) | NSD | NSD | SIG | NSD | |||
Kalmus et al. (49) | NSD | NSD | NSD | NSD | |||
Truchetti et al. (50) | SIG | NSD | NSD | ||||
Cortinhas et al. (51) | NSD | NSD | NSD | ||||
Viveros et al. (52) | NSD | SIG | SIG | ||||
McDougall et al. (53) | NSD | SIG | NSD | ||||
POSITIVELY CONTROLLED TRIALS – TESTING A NON-INFERIORITY OR “EQUIVALENCY” HYPOTHESIS | |||||||
McDougall et al. (54) | NSD | SIG | Defined as CC | ||||
McDougall et al. (21) | NSD | SIG | NSD | Defined as CC | NSD | NSD | |
Schukken et al. (55) | NIc | NSD | NI | ||||
Vasquez et al. (56) | NI | NI | NI | NI | |||
Bryan et al. (57) | NSD | NSD | Defined as CC | ||||
Tomazi et al. (58) | Inconclusive | Inconclusive | NI |
No significant difference;
statistically significant difference among treatments;
non-inferior.